HomeCoronavirus NewsNOVAVAX COVID-19 vaccine: Has 90% efficacy against COVID

NOVAVAX COVID-19 vaccine: Has 90% efficacy against COVID

NOVAVAX COVID-19 vaccine: Has 90% efficacy against COVID

On 14th June 2021, The US Biotechnology Company NOVAVAX has made an announcement that its COVID-19 vaccine named NOVAVAX has resulted 100% protection against the moderate and severe symptoms of the Covid-19 disease and has also shown 90.4 (%) percent efficacy overall in phase 3 trials.

What is NOVAVAX COVID-19 (Corona) vaccine:

  • NOVAVAX COVID-19 vaccine (NVX-CoV2373) is known as a protein-based vaccine and made from the genetic sequence of the first strain of SARS-CoV-2.
  • NOVAVAX received enrollments of 29,960 participants across 119 sites in the United States and Mexico to examine the safety, efficacy, and immunogenicity of the vaccine.

Follow on Social accounts

To Join Facebook PageJoin Us
To Join InstagramJoin Us
NOVAVAX COVID-19 vaccine: Has 90% efficacy against COVID 1
Yashhuuhttps://www.prepareexams.com
I love To Write Articles, I Write articles in many fields technology, news, educations, exams, gadgets reviews, coding, Apps. Facebook
- Advertisment -

Latest Articles